Discovery of ligands for directed-differentiation of stem cells
Discovery of ligands for directed-differentiation of stem cells
批准号:
8240375
负责人:
KIT S LAM
金额:
$19.21万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-12-15 至 2013-11-30
关键词:
Amino AcidsApoptoticBindingBiochemicalBiologicalBone MarrowCancer Cell GrowthCancer cell lineCell AdhesionCell Surface ReceptorsCell surfaceCellsChemicalsCollagenDifferentiation and GrowthEngineeringExtracellular MatrixExtracellular Matrix ProteinsFibronectinsFlow CytometryFocal Adhesion Kinase 1GlycopeptidesGoalsGrowthGrowth FactorHomingHumanHydrogelsImageIntegrin BindingKnock-in MouseLabelLamininLibrariesLifeLigandsMaintenanceMediatingMethodsMitogen-Activated Protein KinasesMusNatureNeuronsOligodendrogliaPeptide FragmentsPeptide Phage Display LibraryPeptidesPlayPropertyProteinsProteolysisRGD (sequence)ReporterResearchResistanceRoleScreening procedureSignal TransductionSolidStem Cell ResearchStem cellsStromal CellsStructureSurfaceTherapeutic Human Experimentationbasecancer cellcell behaviorcell growthcell typecombinatorialcombinatorial chemistrydesignhuman embryonic stem cellin vivoinduced pluripotent stem cellnerve stem cellnervous system disordernoveloligodendrocyte precursorosteogenicpeptidomimeticspluripotencyprecursor cellprotein aminoacid sequencereceptorresearch studyscaffoldsmall moleculestemstem cell differentiationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In addition to discovering soluble small molecule for hESC/iPSC maintenance and directed differentiation, combinatorial chemistry can also serve as an excellent tool for the identification of extracellular matrix (ECM) mimics that can further facilitate the maintenance or specific- differentiation of hESC/iPSCs. The one-bead-one-compound (OBOC) combinatorial chemistry invented by Dr. Lam is particularly suited for the discovery of ECM mimics or other functional ligands against unique cell surface receptors of stem cells. We have recently developed a one- bead-two-compound (OB2C) library method by incorporating a known cell adhesion peptide (e.g. an integrin binding ligand) on the outer layer of every bead of the OBOC library. As a result, every bound cell will be exposed to the library compound displayed on the surface of each bead. We have generated genetically-labeled Olig2-GFP knock-in hESC/iPSC reporter lines that can be conveniently used as readouts in the proposed combinatorial library screening for directed-differentiation toward various lineages. Specific aims of this proposal are: 1. To design and synthesize several OBOC and OB2C combinatorial libraries for the discovery of cell surface acting molecules that can induce directed-differentiation of hESCs or iPSCs. 2. To use live Olig2-GFP knock-in reporter hESC/iPSC lines in conjunction with immunocytochemical methods to screen various OB2C libraries (from aim 1) for directed-differentiation into oligodendroglial progenitor cells. 3. To fully characterize effects of the ligands and molecules identified in aim 2 on hESC/iPSC growth and differentiation using a range of biological and biochemical approaches. To optimize and use these ligands in a novel chemically-defined self- assemble PVA-based hydrogel as artificial ECM to support stem cell growth and directed- differentiation into oligodendroglial progenitor cells [OPCs]. Impact The proposed research will enable us to discover synthetic molecules that bind to unique receptors on the surface of hESC/iPSCs. Some of these molecules may support the growth of hESC/iPSCs while maintaining its "stem-ness". Others may induce specific cell signaling and oligodendrocyte differentiation. Our long term goal is to direct-differentiate oligodendrocyte precursor cells further for the treatment of neurological diseases.
PUBLIC HEALTH RELEVANCE: In addition to discovering soluble small molecule for hESC/iPSC maintenance and directed differentiation, combinatorial chemistry can also serve as an excellent tool for the identification of extracellular matrix (ECM) mimics that can further facilitate the maintenance or specific- differentiation of hESC/iPSCs. The one-bead-one-compound (OBOC) and one-bead-two- compound (OB2C) combinatorial chemistry invented by Dr. Lam is particularly suited for the discovery of ECM mimics or other functional ligands against unique cell surface receptors of stem cells. Genetically-labeled Olig2-GFP knock-in hESC/iPSC reporter lines will be used as readouts in the proposed combinatorial library screening for directed-differentiation into oligodendroglial progenitor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Mannose 6-Phosphate Decorated Transformable Nanoplatform for Targeted Uptake in HER2+ Tumors
-
批准号:10381225
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2021
-
负责人:KIT S LAM
-
依托单位:
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
-
批准号:10524157
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2020
-
负责人:KIT S LAM
-
依托单位:
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
-
批准号:10737741
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2020
-
负责人:KIT S LAM
-
依托单位:
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
-
批准号:10553132
-
项目类别:
-
资助金额:$56.02万
-
财政年份:2020
-
负责人:KIT S LAM
-
依托单位:
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
-
批准号:10348732
-
项目类别:
-
资助金额:$56.27万
-
财政年份:2020
-
负责人:KIT S LAM
-
依托单位:
Therapeutic Targeting Agents for Ovarian Cancer
-
批准号:9477423
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2015
-
负责人:KIT S LAM
-
依托单位:
Therapeutic Targeting Agents for Ovarian Cancer
-
批准号:9259922
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2015
-
负责人:KIT S LAM
-
依托单位:
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
-
批准号:9751792
-
项目类别:
-
资助金额:$56.33万
-
财政年份:2015
-
负责人:KIT S LAM
-
依托单位:
Genetically encoded reporters of integrated neural activity for functional mapping of neural circuitry
-
批准号:9130272
-
项目类别:
-
资助金额:$68.25万
-
财政年份:2014
-
负责人:KIT S LAM
-
依托单位:
Genetically encoded reporters of integrated neural activity for functional mapping of neural circuitry
-
批准号:8934232
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2014
-
负责人:KIT S LAM
-
依托单位:
Genetically encoded reporters of integrated neural activity for functional mapping of neural circuitry
-
批准号:8827140
-
项目类别:
-
资助金额:$70.21万
-
财政年份:2014
-
负责人:KIT S LAM
-
依托单位:
Discovery of Death Ligands Against Cancers
-
批准号:8427229
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2012
-
负责人:KIT S LAM
-
依托单位:
Discovery of Death Ligands Against Cancers
-
批准号:8547790
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2012
-
负责人:KIT S LAM
-
依托单位:
Discovery of Death Ligands Against Cancers
-
批准号:8721882
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2012
-
负责人:KIT S LAM
-
依托单位:
Multi-functional Nanocarrier against Canine Lymphoma
-
批准号:8247714
-
项目类别:
-
资助金额:$59.62万
-
财政年份:2011
-
负责人:KIT S LAM
-
依托单位:
Multi-functional Nanocarrier against Canine Lymphoma
-
批准号:8611720
-
项目类别:
-
资助金额:$49.92万
-
财政年份:2011
-
负责人:KIT S LAM
-
依托单位:
Multi-functional Nanocarrier against Canine Lymphoma
-
批准号:8338962
-
项目类别:
-
资助金额:$2.68万
-
财政年份:2011
-
负责人:KIT S LAM
-
依托单位:
Multi-functional Nanocarrier against Canine Lymphoma
-
批准号:8424330
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2011
-
负责人:KIT S LAM
-
依托单位:
Discovery of ligands for directed-differentiation of stem cells
-
批准号:8399060
-
项目类别:
-
资助金额:$21.99万
-
财政年份:2011
-
负责人:KIT S LAM
-
依托单位:
Targeting nanotherapeutics against murine and feline oral cancer
-
批准号:9353406
-
项目类别:
-
资助金额:$52.44万
-
财政年份:2011
-
负责人:KIT S LAM
-
依托单位:
海外基金